HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Somerville, R. A. Articles by Fernie, K. Search for Related Content PubMed PubMed Citation Articles by Somerville, R. A. Articles by Fernie, K. Agricola Articles by Somerville, R. A. Articles by Fernie, K.

Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrP^Sc

Neuropathogenesis Unit, Institute for Animal Health, West Mains Road, Edinburgh EH9 3JF, UK

Correspondence
Robert A. Somerville
robert.somerville{at}bbsrc.ac.uk

Transmissible spongiform encephalopathies (TSEs), sometimes known as prion diseases, are caused by an infectious agent whose molecular properties have not been determined. Traditionally, different strains of TSE diseases are characterized by a series of phenotypic properties after passage in experimental animals. More recently it has been recognized that diversity in the degree to which an abnormal form of the host protein PrP, denoted PrP^Sc, is glycosylated and the migration of aglycosyl forms of PrP^Sc on immunoblots may have some differential diagnostic potential. It has been recognized that these factors are affected by the strain of TSE agent but also by other factors, e.g. location within the brain. This study shows in some cases, but not others, that host PrP genotype has a major influence on the degree of PrP^Sc glycosylation and migration on gels and provides further evidence of the effect of brain location. Accordingly both the degree of glycosylation and the apparent molecular mass of PrP^Sc may be of some value for differential diagnosis between TSE strains, but only when host effects are taken into account. Furthermore, the data inform the debate about how these differences arise, and favour hypotheses proposing that TSE agents affect glycosylation of PrP during its biosynthesis.

This article has been cited by other articles:

				J. R. Piro, B. T. Harris, K. Nishina, C. Soto, R. Morales, J. R. Rees, and S. Supattapone Prion Protein Glycosylation Is Not Required for Strain-Specific Neurotropism J. Virol., June 1, 2009; 83(11): 5321 - 5328. [Abstract] [Full Text] [PDF]

				J. Novakofski, M. S. Brewer, N. Mateus-Pinilla, J. Killefer, and R. H. McCusker Prion biology relevant to bovine spongiform encephalopathy J Anim Sci, June 1, 2005; 83(6): 1455 - 1476. [Abstract] [Full Text] [PDF]